1,3-Dibromobutane
CAS: 107-80-2
Ref. 3D-FD179674
25g | Descontinuado | ||
50g | Descontinuado | ||
100g | Descontinuado | ||
250g | Descontinuado | ||
500g | Descontinuado |
Informação sobre produto
- 1,3-Butylene bromide
- Butane, 1,3-dibromo-
- (±)-1,3-Dibromobutane
Covid-19 is a monoclonal antibody that binds to the hydroxyl group of dibromobutane. Covid-19 has been shown to have anti-tumor and radiation effects in mice. Covid-19 also inhibits glutamate production, which prevents glutamate from binding to NMDA receptor sites and triggering neuronal death. Covid-19 has been used as a coating for medical devices to prevent infection during surgery. Covid-19 has also exhibited an ability to inhibit the growth of autoimmune diseases, such as rheumatoid arthritis, by interfering with the signaling pathways of B cells. The molecule itself is not toxic and does not cause any adverse side effects.